Former Colt, Bear take tax lawsuit to Ohio’s top court
Former Indianapolis Colts center Jeff Saturday and ex-Chicago Bear linebacker Hunter Hillenmeyer are suing Cleveland over what they consider an “egregious and shameless money grab.”
Bloomberg News
Articles
Indianapolis part of new federal STEM initiative
President Barack Obama drew attention to girls’ science and engineering accomplishments Tuesday as he announced a mentoring effort involving Indianapolis to improve and diversify the nation’s technological work force.
Notre Dame takes lacrosse’s lowest revenue into final four
The University of Notre Dame men’s lacrosse team had a $1.5 million loss last year, highest in the country and more than triple the combined losses of the three other schools competing for the national title this weekend.
Ex-Lilly partner wins latest suit over Actos’ cancer risk
Takeda Pharmaceutical was found not liable for the bladder cancer of two women who used its Actos diabetes medication in the company’s latest trial over the drug. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.
Republic Airways considers ending $3B jet order
The 40 Bombardier CS300 aircraft on order at Republic Airways Holdings Inc. are no longer a top priority as the Indianapolis-based company returns to its roots as a provider of regional flights for larger carriers, CEO Bryan Bedford said.
Indianapolis loses Super Bowl bid to Minneapolis and its new stadium
Despite having what several NFL executives said was the strongest proposal, Indianapolis lost out on hosting the 2018 championship game to a city with a new, $975 million stadium in the wings.
NFL owners to consider expansion of playoffs
In addition to deciding which city will host the 2018 Super Bowl, National Football League owners on Tuesday will try to determine whether to add two more teams to the playoffs.
Drugmaker hid diabetes drug’s cancer risks, lawyer says
Takeda Pharmaceutical Co. executives covered up the cancer risks of its diabetes medicine Actos to protect billions of dollars in sales, a lawyer for two women argued.
Simon partner looks to buy out co-owners in expansion drive
Paris-based Klepierre SA, whose largest shareholder is Simon Property Group Inc., plans to spend as much as $686 million a year on expansion.
City unveils first car-sharing charging station
A French company on Monday unveiled its first electric car-charging station in Indianapolis, where drivers will be able to rent plug-in vehicles for short-term trips later this year.
Comcast spinoff names Insight co-founder Willner as CEO
Comcast is planning to spin off operations that serve about 2.5 million customers in Indiana, Alabama, Michigan and other states after completing the purchase of Time Warner Cable.
Lilly loses patent dispute over Alimta in London court
Eli Lilly and Co. lost a United Kingdom lawsuit over its Alimta cancer treatment when a judge ruled Thursday that a generic version planned by Actavis Plc doesn’t breach European patents.
WellPoint foe leads plan to reveal health prices to consumers
WellPoint Inc. competitor UnitedHealth Group Inc., the largest U.S. health insurer, will lead an industry effort to throw a spotlight on the prices paid for health-care services, making their costs available to consumers on the Internet.
Lilly says its once-daily insulin tops competitor’s drug
Eli Lilly & Co. said its experimental insulin helped diabetic patients more than Sanofi’s biggest product in studies that also raised some safety risks.
U.S. House votes to revive expired research tax credit
The 274-131 vote follows calls to restore the credit by a coalition of companies including Indianapolis-based Eli Lilly and Co. and Texas Instruments Inc.
UPDATE: Toyota to quit Camry production in Lafayette
Fuji Heavy Industries Ltd., the maker of Subaru cars, will stop making Camry cars in the U.S. for its largest shareholder, Toyota Motor Corp., in the second half of 2016. About 100,000 Camrys are made annually at the Indiana plant.
Bayer’s $14.2 billion Merck buy shows pharma strategy split
Bayer AG’s $14.2 billion acquisition of Merck & Co. is the latest in a series of big pharma deals and it exposes a deepening split in the way drugmakers approach their portfolios.
Insurers say most Obamacare enrollees paying premiums
Three large health insurers including Indianapolis-based WellPoint Inc. and Aetna Inc. say that a high percentage of their new Obamacare customers are paying their first premiums, partly undermining a Republican criticism of enrollment in the program.
Drug prices surge as generics, niche treatments eat profit
Since 2007, the cost of brand-name medicines has jumped, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure and even erections, according to an analysis conducted for Bloomberg News.
WellPoint shares rise after better-than-expected quarter
The Indianapolis-based health insurer increased its profit forecast after Obamacare enrollments boosted quarterly results.